3-36993441-C-G

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP6_Very_Strong

The ENST00000413740.2(MLH1):​c.-107C>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000307 in 1,008,238 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.000031 ( 0 hom. )

Consequence

MLH1
ENST00000413740.2 5_prime_UTR

Scores

2

Clinical Significance

Likely benign reviewed by expert panel P:1U:2B:4

Conservation

PhyloP100: -0.325

Publications

1 publications found
Variant links:
Genes affected
MLH1 (HGNC:7127): (mutL homolog 1) The protein encoded by this gene can heterodimerize with mismatch repair endonuclease PMS2 to form MutL alpha, part of the DNA mismatch repair system. When MutL alpha is bound by MutS beta and some accessory proteins, the PMS2 subunit of MutL alpha introduces a single-strand break near DNA mismatches, providing an entry point for exonuclease degradation. The encoded protein is also involved in DNA damage signaling and can heterodimerize with DNA mismatch repair protein MLH3 to form MutL gamma, which is involved in meiosis. This gene was identified as a locus frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). [provided by RefSeq, Aug 2017]
MLH1 Gene-Disease associations (from GenCC):
  • Lynch syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, G2P
  • Lynch syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp
  • Muir-Torre syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, G2P, Orphanet
  • mismatch repair cancer syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, G2P, ClinGen
  • Lynch syndrome 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • ovarian cancer
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • malignant pancreatic neoplasm
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • rhabdomyosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • prostate cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • breast cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP6
Variant 3-36993441-C-G is Benign according to our data. Variant chr3-36993441-C-G is described in ClinVar as Likely_benign. ClinVar VariationId is 89587.Status of the report is reviewed_by_expert_panel, 3 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000413740.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MLH1
NM_000249.4
MANE Select
c.-107C>G
upstream_gene
N/ANP_000240.1P40692-1
MLH1
NM_001354628.2
c.-107C>G
upstream_gene
N/ANP_001341557.1A0A087WX20
MLH1
NM_001354629.2
c.-107C>G
upstream_gene
N/ANP_001341558.1A0AAQ5BGZ2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MLH1
ENST00000413740.2
TSL:1
c.-107C>G
5_prime_UTR
Exon 1 of 15ENSP00000416476.2H0Y806
MLH1
ENST00000673673.2
c.-107C>G
5_prime_UTR
Exon 1 of 18ENSP00000500979.2A0A669KAW3
MLH1
ENST00000536378.5
TSL:2
c.-739C>G
5_prime_UTR
Exon 1 of 18ENSP00000444286.2P40692-2

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
0.0000307
AC:
31
AN:
1008238
Hom.:
0
Cov.:
14
AF XY:
0.0000307
AC XY:
16
AN XY:
521466
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
24758
American (AMR)
AF:
0.00
AC:
0
AN:
43480
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23210
East Asian (EAS)
AF:
0.000796
AC:
30
AN:
37672
South Asian (SAS)
AF:
0.00
AC:
0
AN:
76814
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52462
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4486
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
699910
Other (OTH)
AF:
0.0000220
AC:
1
AN:
45446
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
3
6
10
13
16
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
2
Colorectal cancer, hereditary nonpolyposis, type 2 (3)
1
-
-
Familial cancer of breast (1)
-
1
-
Hereditary cancer-predisposing syndrome (1)
-
-
1
Hereditary nonpolyposis colorectal neoplasms (1)
-
-
1
Lynch syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
5.0
DANN
Benign
0.56
PhyloP100
-0.33
PromoterAI
-0.24
Neutral
Mutation Taster
=103/197
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.27
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.27
Position offset: 0

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs587778886; hg19: chr3-37034932; API